{{Rsnum
|rsid=3905011
|Gene=CACNA1E
|Chromosome=1
|position=181576458
|Orientation=minus
|GMAF=0.3935
|Gene_s=CACNA1E
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 25.7 | 53.1 | 21.2
| HCB | 51.8 | 39.4 | 8.8
| JPT | 48.7 | 38.9 | 12.4
| YRI | 27.2 | 50.3 | 22.4
| ASW | 26.3 | 59.6 | 14.0
| CHB | 51.8 | 39.4 | 8.8
| CHD | 49.5 | 38.5 | 11.9
| GIH | 35.6 | 43.6 | 20.8
| LWK | 26.4 | 50.0 | 23.6
| MEX | 46.6 | 43.1 | 10.3
| MKK | 39.1 | 46.2 | 14.7
| TSI | 46.1 | 40.2 | 13.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=22427875
|Title=CACNA1E Variants Affect Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 3
|OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}